Equity access and economic evaluation in rare diseases: the impact of orphan drug legislation on health policy and patient care
Gespeichert in:
Verfasser / Beitragende:
[Nick Bosanquet, Gianfranco Domenighetti, Ariel Beresniak, Jean-Paul Auray, Luca Crivelli, L. Richard, P. Howard]
Ort, Verlag, Jahr:
2003
Enthalten in:
Pharmaceutical Development and Regulation, 1/3(2003), 151-157
Format:
Artikel